Home
About
Contact
DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Your search for
Hematology | All Regions
returned
21
studies.
Active, currently enrolling
Who can join
A Phase I/II, Open-Label, Single-Arm, Two-Part Trial to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination With Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Keywords:
Relapsed; Refractory; B-NHL;Hematology;Oncology (Pediatrics);
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
VS-6063 (defactinib) in Patients with Tumors with NF2 Loss (MATCH Substudy)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
Phase II Study of Trametinib in Patients with BRAF Fusions, or with Non-V600E, Non-V600K BRAF Mutations (MATCH Substudy)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
Ado-trastuzumab Emtansine in Patients with Tumors with HER2 Amplification (Except Breast and Gastric/Gastro-Esophageal Junction (GEJ) Adenocarcinomas) (MATCH Substudy)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
GDC-0032 (taselisib) in Patients with Tumors (other than breast cancer) with PIK3CA Mutation but without KRAS Mutation or PTEN Loss (MATCH Substudy)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
Phase II Study of Dabrafenib and Trametinib in Patients with Tumors with BRAF V600E or V600K Mutations (Excluding Melanoma, Thyroid Cancer, Colorectal Adenocarcinoma, and Non-Small Cell Lung Cancer) (MATCH Substudy)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
Phase II Study of Crizotinib in Patients with ROS1 Translocations (Other Than Patients with Non-Small Cell Lung Cancer) (MATCH Substudy)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
Crizotinib in Patients with Tumors (other Than Adenocarcinoma of Lung or ALCL) with ALK Rearrangements (MATCH Substudy)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Keywords:
Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia; Lymphoid;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A Phase I Study With an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma
Keywords:
Oncology (Adult);Hematology; Neoplasms by Histologic…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
1
2
3